Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 19 Jul 2017 |
10 | Order | 20 Mar 2024 |
2 | Reply to Exam Report (MIS-R) | 16 Nov 2017 |
3 | Incorpration Certificate | 18 Jul 2018 |
4 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 28 Feb 2019 |
5 | Authorization Letter | 07 Mar 2019 |
6 | Journal Copy | 30 May 2019 |
7 | TM-O(NOTICE OF OPPOSITION) | 17 Jul 2019 |
8 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 05 Mar 2024 |
9 | TM-M(REQUEST FOR PAYMENT OF MISC. FEE FOR OTHER PURPOSE) | 07 Mar 2024 |
1 | Dispatching of Examination Report for : 3594874 via Email | 5391879 | 2289693 | 14 Nov 2017 |
2 | Hearing Notice (Show Cause) | 7587951 | 3715906 | 08 Jan 2019 |
3 | Tribunal Accepted Notice for : 3594874 | 7915806 | 3867917 | 07 Mar 2019 |
4 | Opposition Notice | 8620423 | 4256902 | 19 Jul 2019 |
5 | Hearing Notice | 17334956 | 6532994 | 07 Feb 2024 |
The application for Daxenil was made on 19 July 2017.
The trademark applicant for Daxenil is STRIDES PHARMA SCIENCE.
Daxenil is applied in class(es) 5.
Application for Daxenil is on Opposed stage.
Application Id allotted to Daxenil is 3594874.
Trademark agent or attorney for the application is Altacit Global.
Daxenil filed with the Intellectual property office as a WORD.